The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

AsiaTIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

CSS

The Only Event in Japan with Comprehensive Coverage of Oligonucleotides and Peptides

February 26 - February 28,--> 2013 · Tokyo, Japan

Event Overview

Event Overview

Gain Knowledge » Build Your Network » Move Projects Forward

Get Event Information

Join our priority contact list and receive the latest event news.

Now in its 5th year, AsiaTIDES: Oligonucleotide and Peptide Research, Technology and Product Development continues to be the premier forum to get a comprehensive update, meet key players and increase your knowledge of the oligonucleotide- and peptide-based therapeutics fields.

» Read more about AsiaTIDES

"The preeminent conference in Japan on the development of therapeutic oligos and peptides, and brings together a majority of the leaders in the field." - Patrick C. Reid, Ph.D., Chief Scientific Officer, PeptiDream Inc., Japan

Scientific and Business Advances that Impact the Future

Arthur M. Krieg, M.D.
Oligonucleotide Therapeutics
Outlook
LNP Delivery
of siRNA
Yoshiaki Kiso, Ph.D.
Click Peptide
Concept
Ping Qiu, M.D.
Omontys from
Bench to
Bedside

Arthur M. Krieg, M.D.Chief Executive Officer, RaNA Therapeutics, USA

Etsuo Ohshima, Ph.D.Managing Officer and Vice President, Head, Research Division, Kyowa Hakko Kirin Co., Ltd., Japan

Yoshiaki Kiso, Ph.D.Professor, Laboratory of Peptide Science, Nagahama Institute of Bio-Science and Technology, Japan

Ping Qiu, M.D.Senior Medical Director, Clinical Science, Takeda Global Research and Development Inc., USA

"A well-organized, informative meeting providing a great overview of the oligonucleotide field and the opportunity to network with current and potential collaborators in a nice setting." - Pamela A. Pavco, Ph.D., Chief Development Officer, RXi Pharmaceuticals, USA

New for 2013

  • Hear the Industry's First Reports from Japanese Companies on their US Collaborations to Understand Deal Drivers
  • New Joint Session: OSWG and JPMA on Preclinical and Clinical Safety Assessment so You Can Plan Regulatory Strategies

Only Available at AsiaTIDES

  • Clinical Milestones to Benchmark Your Progress
  • Latest Updates to Strategically Plan Your Process and Portfolio Development:
    • Discovery and Preclinical Development
    • Clinical Development of siRNA, miRNA, Aptamers, and Other Oligo Classes
    • Conjugates, Peptide Therapeutics, and Vaccines
    • Manufacturing and Analytical Challenges Session
  • In-Depth Tutorials to Update your Knowledge:
    • Quality by Design/In Process Control Requirements
    • Successful Delivery of Oligonucleotides in vivo: Chemical Modifications and DDS (Drug Delivery Systems)